- decreased locomotor activity / IMPC
- increased circulating phosphate level / IMPC
- increased circulating serum albumin level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- abnormal behavior / IMPC
- increased circulating creatinine level / IMPC
- increased circulating potassium level / IMPC
- increased cardiac stroke volume / IMPC
- decreased thigmotaxis / IMPC
C57BL/6NTac-Rsad2em1(IMPC)H/H
Status | Available to order |
EMMA ID | EM:11809 |
Citation information | RRID:IMSR_EM:11809 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6NTac-Rsad2em1(IMPC)H/H |
Alternative name | |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | Rsad2em1(IMPC)H |
Gene/Transgene symbol | Rsad2 |
Information from provider
Provider | MRC, Medical Research Council |
Provider affiliation | Mary Lyon Centre at MRC Harwell |
Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- increased circulating alkaline phosphatase level / IMPC
- decreased locomotor activity / IMPC
- increased circulating serum albumin level / IMPC
- increased cardiac stroke volume / IMPC
- decreased thigmotaxis / IMPC
- abnormal behavior / IMPC
- increased circulating phosphate level / IMPC
- increased circulating potassium level / IMPC
- increased circulating creatinine level / IMPC
MGI phenotypes (gene matching)
- abnormal T-helper 2 cell differentiation / MGI
- decreased IgG1 level / MGI
- decreased interferon-alpha secretion / MGI
- decreased interferon-beta secretion / MGI
- increased interferon-gamma secretion / MGI
- decreased circulating interferon-alpha level / MGI
- decreased interleukin-13 secretion / MGI
- decreased interleukin-4 secretion / MGI
- decreased interleukin-5 secretion / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).